Diabetic Peripheral Neuropathy (Distal Symmetric Polyneuropathy)
The most likely diagnosis is diabetic peripheral neuropathy (DPN), specifically distal symmetric polyneuropathy (DSPN), which presents classically with bilateral foot numbness and difficulty walking due to loss of protective sensation and large fiber involvement.
Clinical Presentation and Diagnosis
This patient's presentation is textbook for DPN. The bilateral foot numbness with difficulty walking indicates involvement of large nerve fibers responsible for proprioception and balance 1, 2. Diabetic neuropathy is a clinical diagnosis based on the patient's symptoms—distal, symmetrical sensory loss—combined with simple bedside examination 3, 1.
Key Diagnostic Features to Assess:
- Sensory examination: Test pinprick or temperature sensation (small fiber function) and vibration using a 128-Hz tuning fork (large fiber function) 1, 2
- 10-g monofilament testing: Essential to identify loss of protective sensation (LOPS) and risk for ulceration 1, 4, 5
- Ankle reflexes: Often diminished or absent in DPN 6
- Gait assessment: Difficulty walking suggests proprioceptive loss from large fiber involvement 1
The bilateral and symmetrical nature is critical—asymmetrical symptoms should prompt investigation for other etiologies 3.
Differential Considerations
While DPN is the primary diagnosis, diabetic neuropathy is a diagnosis of exclusion 1, 2, 4. You must rule out other treatable causes of peripheral neuropathy:
- Vitamin B12 deficiency
- Hypothyroidism
- Alcohol toxicity
- Neurotoxic medications (chemotherapy)
- Renal disease
- HIV infection
- Chronic inflammatory demyelinating polyneuropathy
- Inherited neuropathies 7
Additionally, consider entrapment neuropathies (tarsal tunnel syndrome, lumbar spinal disease) which can coexist with DPN in diabetic patients 8.
Important Clinical Pitfall
Up to 50% of DPN may be asymptomatic 1, 4, 5. The fact that this patient has symptoms with difficulty walking indicates advanced disease. Without recognition and preventive foot care, these patients face high risk for foot ulcers and amputation 1, 4.
Assessment Timeline
All type 2 diabetes patients should be assessed for DPN at diagnosis, then annually 1, 2, 4. For type 1 diabetes, screening begins 5 years after diagnosis 1, 4.
Associated Complications to Screen
Assess for autonomic neuropathy (orthostatic dizziness, resting tachycardia, gastroparesis, erectile dysfunction) as it frequently coexists with DPN and impacts mortality 1, 6, 5. Screen for diabetic retinopathy and nephropathy, as microvascular complications cluster together 1.
Management Priorities
Optimize glycemic control immediately: This prevents DPN in type 1 diabetes and slows progression in type 2 diabetes, though it cannot reverse neuronal loss 1, 2, 7
Foot protection education: Given LOPS and difficulty walking, this patient needs daily foot inspection, proper footwear, and immediate reporting of any injuries 9
Fall prevention: Large fiber involvement causing proprioceptive loss increases fall risk—consider physical therapy and assistive devices if needed
Pain management (if painful symptoms develop): First-line agents are pregabalin, duloxetine, or gabapentin 1, 6, 4
Electrophysiological testing is rarely needed unless the presentation is atypical or diagnosis unclear 1, 2, 6.